XIAP and glioblastoma: An apoptotic regulation protein BCL-2L12 was found to be overexpressed in nearly all GBMs, and a bunch of X-linked inhibitor of apoptosis (XIAP) are emerging as potential therapeutic targets for GBM [5, 6].